心肌桥接的解剖学风险和并发症

Q4 Medicine
Rupali A. Mahajan, Preeti Meshram, Nisha Vinod Ranadhir, Shantha Hattangadi
{"title":"心肌桥接的解剖学风险和并发症","authors":"Rupali A. Mahajan, Preeti Meshram, Nisha Vinod Ranadhir, Shantha Hattangadi","doi":"10.24969/hvt.2022.331","DOIUrl":null,"url":null,"abstract":"Objective: Myocardial bridging (MB) is an asymptomatic, benign, and congenital coronary anomaly with several possible manifestations. MB is formed by a segment of a coronary artery taking an intra-myocardial course.  As of date, huge knowledge gap exists in the literature in terms of MB and its associated complications.\n\nMethods: This single-centre, observational, non-randomised study was conducted over a period of 20 months to identify the rare anomalies such as MB using coronary angiograms.\n\nResults: Eight of 400 cases screened have been found to have MB bridging in mid left anterior descending artery (LAD) segment. The male to female ratio was 7:1 all within an age range of 24 years to 45 years. Most of the patients were asymptomatic with no history of drug usage (6/8) and family history (3/8) of coronary disorders. In symptomatic cases, the most common presenting symptoms were observed to be typical chest pain, dyspnea, nausea, light-headedness, or headaches, diaphoresis, and tachycardia. In most of the patients, MB showed systolic shortening with resultant flow limitation on coronary angiography. The segments were reported to be 1 mm to 10 mm in size and traversed 1 cm to 3 cm length. All the patients were treated symptomatically and were kept on follow-up. No mortality was observed in any case with MB.\n\nConclusion:  Even though MB is a benign condition, but its vast array of related complications was reported to be life threatening and require prompt diagnosis and treatment. This study focus on such MB related risks by highlighting the importance of differential diagnosis and the treatment followed by to avoid all possible complications in all those patients presenting with possible signs and symptoms.\n","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anatomical risks and complications associated with myocardial bridging\",\"authors\":\"Rupali A. Mahajan, Preeti Meshram, Nisha Vinod Ranadhir, Shantha Hattangadi\",\"doi\":\"10.24969/hvt.2022.331\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Myocardial bridging (MB) is an asymptomatic, benign, and congenital coronary anomaly with several possible manifestations. MB is formed by a segment of a coronary artery taking an intra-myocardial course.  As of date, huge knowledge gap exists in the literature in terms of MB and its associated complications.\\n\\nMethods: This single-centre, observational, non-randomised study was conducted over a period of 20 months to identify the rare anomalies such as MB using coronary angiograms.\\n\\nResults: Eight of 400 cases screened have been found to have MB bridging in mid left anterior descending artery (LAD) segment. The male to female ratio was 7:1 all within an age range of 24 years to 45 years. Most of the patients were asymptomatic with no history of drug usage (6/8) and family history (3/8) of coronary disorders. In symptomatic cases, the most common presenting symptoms were observed to be typical chest pain, dyspnea, nausea, light-headedness, or headaches, diaphoresis, and tachycardia. In most of the patients, MB showed systolic shortening with resultant flow limitation on coronary angiography. The segments were reported to be 1 mm to 10 mm in size and traversed 1 cm to 3 cm length. All the patients were treated symptomatically and were kept on follow-up. No mortality was observed in any case with MB.\\n\\nConclusion:  Even though MB is a benign condition, but its vast array of related complications was reported to be life threatening and require prompt diagnosis and treatment. This study focus on such MB related risks by highlighting the importance of differential diagnosis and the treatment followed by to avoid all possible complications in all those patients presenting with possible signs and symptoms.\\n\",\"PeriodicalId\":32453,\"journal\":{\"name\":\"Heart Vessels and Transplantation\",\"volume\":\"40 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Heart Vessels and Transplantation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24969/hvt.2022.331\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Vessels and Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24969/hvt.2022.331","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:心肌桥(MB)是一种无症状、良性的先天性冠状动脉异常,有几种可能的表现。MB是由一段冠状动脉在心肌内运动形成的。迄今为止,关于MB及其相关并发症的文献存在巨大的知识缺口。方法:这项单中心、观察性、非随机研究进行了为期20个月的时间,通过冠状动脉造影来识别罕见的异常,如MB。结果:400例患者中有8例发现左前降支中段有MB桥。年龄在24岁至45岁之间,男女比例为7:1。大多数患者无症状,无用药史(6/8),无冠心病家族史(3/8)。在有症状的病例中,最常见的症状是典型的胸痛、呼吸困难、恶心、头晕或头痛、出汗和心动过速。在大多数患者中,冠状动脉造影显示MB收缩缩短,导致血流受限。据报道,这些片段的尺寸为1毫米至10毫米,长度为1厘米至3厘米。所有患者均对症治疗并随访。结论:尽管MB是一种良性疾病,但据报道其大量相关并发症危及生命,需要及时诊断和治疗。本研究的重点是通过强调鉴别诊断和治疗的重要性,以避免所有出现可能体征和症状的患者出现所有可能的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Anatomical risks and complications associated with myocardial bridging
Objective: Myocardial bridging (MB) is an asymptomatic, benign, and congenital coronary anomaly with several possible manifestations. MB is formed by a segment of a coronary artery taking an intra-myocardial course.  As of date, huge knowledge gap exists in the literature in terms of MB and its associated complications. Methods: This single-centre, observational, non-randomised study was conducted over a period of 20 months to identify the rare anomalies such as MB using coronary angiograms. Results: Eight of 400 cases screened have been found to have MB bridging in mid left anterior descending artery (LAD) segment. The male to female ratio was 7:1 all within an age range of 24 years to 45 years. Most of the patients were asymptomatic with no history of drug usage (6/8) and family history (3/8) of coronary disorders. In symptomatic cases, the most common presenting symptoms were observed to be typical chest pain, dyspnea, nausea, light-headedness, or headaches, diaphoresis, and tachycardia. In most of the patients, MB showed systolic shortening with resultant flow limitation on coronary angiography. The segments were reported to be 1 mm to 10 mm in size and traversed 1 cm to 3 cm length. All the patients were treated symptomatically and were kept on follow-up. No mortality was observed in any case with MB. Conclusion:  Even though MB is a benign condition, but its vast array of related complications was reported to be life threatening and require prompt diagnosis and treatment. This study focus on such MB related risks by highlighting the importance of differential diagnosis and the treatment followed by to avoid all possible complications in all those patients presenting with possible signs and symptoms.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
45
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信